Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Melatonin may help treat PCOS symptoms in rats.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.